pharma · Ependymoma, Medulloblastoma · chronically occluded coronary artery
Ishita Pharma -
ISTA Pharma Limited
ISTA Pharma is a pharma organization headquartered in GB. Primary therapeutic focus areas include Ependymoma, Medulloblastoma, chronically occluded coronary artery, Hereditary Angioedema, Acute kidney injury, knee osteoa
Mumbai, IN HQ
3 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Employees
- 3
- Programs
- 8
- Drugs
- 19
- Patents
- 0
RCAPHM18_0018
Phase 3 · small molecule · Hirschsprung's disease
RCAPHM18_0018 for Hirschsprung's disease is a Phase 3 program (small_molecule) at ISTA Pharma Limited with 1 ClinicalTrials.gov record(s).
Internal code RCAPHM18_0018
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ISTA Pharma Limited
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Hirschsprung's disease
- Status
- active
- Trials
- 1